U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS
This repository is under review for potential modification in compliance with Administration directives.

Showing 1 - 10 of 15 results

Status:
Investigational

Class (Stereo):
CHEMICAL (ABSOLUTE)


Examorelin (Hexarelin) is a hexapeptide (His-D-2-methyl-Trp-Ala-Trp-D-Phe-Lys-NH2) that stimulates the release of growth hormone lease through binding to the growth hormone secretagogue receptor (GHSR). Hexarelin might have direct cardiovascular acti...
Status:
Investigational

Class (Stereo):
CHEMICAL (ABSOLUTE)



Tabimorelin is an orally active and selective growth hormone secretagogue (GHS) that was derived from growth hormone-releasing peptide-1(GHRP-1) via ipamorelin by a peptidomimetic approach. Tabimorelin inhibits both on gut and liver CYP3A4 activity. ...
Status:
Investigational

Class (Stereo):
CHEMICAL (ABSOLUTE)



Ibutamoren (L-163,191 MK-0677) is a spiropiperidine agonist of the ghrelin receptor and a growth hormone secretagogue. Ibutamoren mimics the actions of growth hormone releasing peptide-6 to increase serum levels of serum insulin-like growth factor-I ...
Status:
Investigational

Class (Stereo):
CHEMICAL (ABSOLUTE)



Anamorelin is a first-in-class, orally active ghrelin receptor agonist that binds and stimulates the growth hormone secretagogue receptor centrally, thereby mimicking the appetite-enhancing and anabolic effects of ghrelin. Anamorelin is under develop...
Status:
Investigational

Class (Stereo):
CHEMICAL (ABSOLUTE)


Status:
Designated

Class (Stereo):
CHEMICAL (ABSOLUTE)



Growth hormone releasing hexapeptide (GHRP-6) is a synthetic met-enkephalin analog that induces the release of growth hormone in vivo through binding of the ghrelin receptor. GHRP-6 increases proliferation in astrocytes through a mechanism that invol...
Status:
US Previously Marketed
First approved in 2017

Class (Stereo):
CHEMICAL (ABSOLUTE)



Macimorelin (AEZS 130) is an orally active, small-molecule, peptidomimetic growth hormone secretagogue receptor (GHSR1A) agonist (ghrelin analogue), being developed by AEterna Zentaris for the diagnosis of adult growth hormone deficiency (AGHD; somat...
Status:
Possibly Marketed Outside US
First approved in 2017

Class (Stereo):
CHEMICAL (ABSOLUTE)



Capromorelin is a potent ghrelin receptor agonist. Capromorelin is indicated for appetite stimulation in dogs. Plasma insulin-like growth factor-I (IGF-I) was elevated progressively over a 5-d course of daily oral dosing in dogs. In healthy older adu...
Status:
Possibly Marketed Outside US

Class (Stereo):
CHEMICAL (ABSOLUTE)



Pralmorelin [GPA 748, GHRP 2, growth hormone-releasing peptide 2, KP-102 D, KP 102 LN] is an orally active, synthetic growth hormone-releasing peptide from a series of compounds that were developed by Polygen in Germany and Tulane University in the U...
Status:
Investigational

Class (Stereo):
CHEMICAL (ABSOLUTE)



Ibutamoren (L-163,191 MK-0677) is a spiropiperidine agonist of the ghrelin receptor and a growth hormone secretagogue. Ibutamoren mimics the actions of growth hormone releasing peptide-6 to increase serum levels of serum insulin-like growth factor-I ...

Showing 1 - 10 of 15 results